drugset / Trial / NCT06104917
Effect of Maolactin on Gastrointestinal Tract (GIT) Health
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a randomized, double-blind, placebo-controlled, 3 arm parallel group study of 12 weeks duration, with a 4-week run-in period as the control phase and an 8-week intervention period, to investigate the effectiveness of the treatment on upper GI disturbance.
Timeline
- Start
- 2024-02-21
- Primary completion
- 2025-07-23
- Completion
- 2025-07-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Maolactin | Protein / enzyme biologic | 250 mg | — |
| Subject | Maolactin | Protein / enzyme biologic | 500 mg | — |